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Abstract
Background: Arsenic exposure induces overproduction of reactive nitrogen species (RNS) in brain tissue and
results in nucleic acid damage to the nerve cells. The 8-nitroguanine is one of the major products formed by the
reaction of guanine, and ONOO
-, and has been used as a popular biomarker of nucleic acid damage due to RNS
attacking. In the present study, we examined whether the administration of taurine can protect against nucleic
acid damage of brain neurons by arsenic-induced RNS.
Materials and methods: Sixty mice (30 male and 30 female) weighing 19.5 ± 1.5 g were divided into 3 groups:
(1) control group, (2) experimental group that received arsenic (As2O3), and (3) antagonistic group that received
taurine with arsenic. Arsenic was administered for 60 days. 8-Nitroguanine expressions in brain neurons of mice
were examined by the immunohistochemical method. Histopathological changes in brain tissues of mice were
observed under light microscope and the immunohistochemistry method was used to investigate 8-nitroguanine
expressions in cerebrum and cerebellum of mice.
Results: In the control group, no abnormal histopathological changes were observed in brain tissue of the mice. In
brain tissue of the mice exposed to arsenic, histopathological results showed swells, evident vacuolar degeneration
in cytoplasm, karyorrhexis and karyolysis. Relatively light pathological changes were observed in brain of the mice
co-administered arsenic and taurine. Little or no expression of 8-nitroguanine in brain tissue was observed in
controls. However, intensive expression of 8-nitroguanine was found in brain tissue of mice exposed to arsenic and
it was mainly distributed in nucleus neighbouring the nuclear membrane, but a little in cytoplasm. A weak
expression of 8-nitroguanine was observed in brain cells of mice co-administered arsenic and taurine.
Conclusions: The brain neurons may be the major target cells of arsenic neurotoxicity. Co-administration of arsenic
and taurine can alleviate DNA damage of brain neurons caused by arsenic through the RNS signal pathway.
Background
Arsenic is a naturally occurring element that is ubiqui-
tously present in the environment. High concentration
of naturally occurring arsenic in drinking water is a
major health problem in different parts of the world.
Arsenic is an environmental contaminant found natu-
rally in ground water. Drinking water contamination by
arsenic remains a major public health problem [1].
Acute and chronic arsenic exposure via drinking water
has been reported in many countries of the world.
There are sufficient epidemiological evidences revealing
a causal association between arsenic exposure and
human disease. Arsenic is also a neurotoxical substance.
Drinking water containing arsenic exceeding 10 μg/L is
harmful to the body [2]. Arsenic contamination also
results from industrial and agricultural uses [3]. The
adverse effect of acute and sub-chronic exposures to
arsenic on the nervous system has been receiving more
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strated that exposure to arsenic results in impaired
learning and concentration for studying, and deterio-
rated pattern memory and attention deficits in humans
[4,5]. It was shown in animal experiments that arsenic
could pass through the blood-brain barrier and invade
the brain parenchyma, and there was a noticeable corre-
lation between the dose of arsenic exposure and its con-
centration in the brain of guinea pigs and rats. Arsenic
exposure renders the brain tissue vulnerable to radical
attack resulting in abnormal apoptosis of neural cells.
However, the mechanism of arsenic induced neurotoxi-
city is unclear to date [6]. It is known that arsenic expo-
sure induces overproduction of reactive oxygen species
(ROS) and reactive nitrogen species (RNS) in the body
and results in nucleic acid damage to the nerve cells [7],
which is one of mechanisms of arsenic toxicity.
Therefore, it indicated that adverse effect of arsenic on
bio-macromolecule maybe avoided or mitigated by
intervention of antioxidants.
8-Nitroguanine is a mutagenic nitrosative DNA lesion
caused by reactive nitrogen and oxygen species, and
now has been used as a potential biomarker of inflam-
mation-related cancers [8]. In the present study, 8-nitro-
guanine was used as a biomarker of nucleic acid damage
[9]. We examined by the immunohistochemical method
the interfering effects of taurine as antioxidants on
nucleic acid damage of mice brain tissue exposed to
arsenic to provide experimental evidences for prevention
and therapy for the arsenic induced brain damage.
Materials and methods
Animal
Sixty mice (Slc/ICR, 30 male and 30 female) weighing
19.5 ± 1.5 g were purchased from Japan SLC (Shizuoka,
Japan) and maintained under specific pathogen free con-
ditions at the Institute for Laboratory Animals of
Suzuka University of Medical Science. They were caged
under a 12 h dark-light cycle in standard conditions of
temperature (18–22 C) and humidity (50 %). The ani-
mals were maintained on a standard diet and water
ad libitum. The animal experiment was performed in
accordance with the Animal Guideline of Suzuka Uni-
versity of Medical Science and in agreement with the
Ethical Committee of Suzuka University of Medical
Science. Mice were 6 weeks old at the beginning of each
experiment. All the mice were sex matched and weighed
before the beginning of the experiment and pooled
together. From this pool, the mice were randomly
assigned to three different groups of twenty each. Group
1 received drinking water alone (as controls). Group 2
received 4 mg/L arsenic trioxide (as experimental
group). Group 3 received both of 4 mg/L arsenic triox-
ide and 150 mg/kg taurine (as antagonistic apply group).
Arsenic trioxide was given through drinking water for
60 days and taurine was affused to the stomach twice a
week. After the last administration, mice were deeply
anesthetized with an intraperitoneal injection of sodium
pentobarbital (30 mg/kg) and were perfused transcar-
dially with phosphate-buffered saline (PBS; 0.01 M
sodium phosphate buffer, pH 7.4, 150 mM NaCl) for 1–
2 min., followed by a fixative, containing 4% paraformal-
d e h y d e ,i nP B S ,p H7 . 0 .A f t e rt h ep e r f u s i o n ,t h eb r a i n s
were removed, and allowed to stand in the same fixative
for 8 hours at 4°C, then rinsed several times with PBS,
a n dk e p ta t4 ° Ci nP B Sw i t h0 . 2 %s o d i u ma z i d eu n t i l
use.
Histopathological examination
The formalin-fixed brain tissues were embedded in par-
affin, sliced at 6 μm thickness, mounted on silanized
slides, and subjected to hematoxylin and eosin staining
according to the routine histopathological methods. His-
topathological changes were observed under an Olym-
pus Type BX51 microscopy.
Immunohistochemical study
We produced specific anti-8-nitroguanine antibody
using 8-nitroguanine-RSA-conjugates. Rabbit polyclonal
anti-8-nitroguanine antibody without cross reaction was
produced as described previously [10,11]. The antibody
was purified using an 8-nitroguanine-conjugate column.
Specificity of the purified antibody was examined by a
dot immunobinding assay and absorption test [10]. Puri-
fied antibody gave a strong immunostaining only on the
spot of 8-nitroguanine conjugate. The immunoreactivity
disappeared only when the antibody was pre-incubated
with 8-nitroguanine. In contrast, immunoreactivity with
8-nitroguanine conjugate did not disappear when the
antibody was pre-incubated with 3-nitrotyrosine, guano-
sine, 8-oxodG, deoxyguanosine, 8-bromoguanosine, and
xanthosine. This purified antibody was presented the
immunoreactivity with free or DNA-associated 8-nitro-
guanine both. 8-Nitroguanine immunoreactivities in the
mouse brain sections were assessed by a peroxidase
anti-peroxidase (PAP) method study as described pre-
viously [12]. Briefly, paraffin sections (6-µm thickness)
were incubated with rabbit polyclonal anti-8-nitrogua-
nine antibody (2 µg/ml) overnight at room temperature.
Then, the sections were incubated for 3 hours with goat
antibody against rabbit IgG (1:200), and were followed
by peroxidase anti-peroxidase complex (1:200). The
sections that had been treated with first and second
antibodies were incubated for 10 min at RT with 3,3′-
diaminobentidine tetrahydrochloride (Dojindo Chemical
Institute; Kumamoto, Japan) as chromogen, which had
been freshly prepared as a solution of 20 mg in 100 ml
PBS that contained 0.01% H202.
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The experimental results are expressed as the mean ±
S.E.M. for twenty mice in each group, and the signifi-
cant difference was analyzed by Student’st - t e s t .A
P value of < 0.05 was considered to be statistically sig-
nificant. We analyzed the correlations of the number
of 8-nitroguanine immunopositive cell in each experi-
ment group.
Results
Quantitative analysis of the experimental animals
All the 60 mice were involved in the analysis of results
without deletion. Alteration of histopathological study in
the brain tissues of mice administrated with arsenic or
arsenic/taurine (Fig. 1).
In the hematoxylin and eosin stained brain sections,
well stained neurons with a distinct nucleus and
nucleolus along with well-stained Nissl substance in
the cytoplasm formed a prominent feature of the cere-
bra and cerebella in the control group. The neuronal
processes as well as the neuropile appeared well
formed in the control group. Microscopic observations
of arsenic administrated group brain sections revealed
structural degeneration of neuron. The cerebral neuron
cells of the mice exposed to arsenic showed cell swel-
ling and evident vacuolar degeneration in cytoplasm
and nucleus, karyorrhexis and karyolysis. Relatively
light pathological changes were showed in the nervous
cells of the mice administered both of arsenic and
taurine.
Formation of 8-nitroguanine in brain tissue of mice
8-nitroguanine immunoreactivity in the brain tissue of
mice is shown in Fig. 2. Little or no expression of 8-
nitroguanine in brain tissue was observed in control
group (Fig. 2, Control). However, intensive expression
of 8-nitroguanine was found in brain cells (Fig. 2,
Arsenic) of mice exposed toa r s e n i c .T h e r ew a sat e n -
dency that 8-nitroguanine was localized in the neuron
cells, whereas it was primarily distributed in the
nucleus neighboring the nuclei membrane. The density
and number of immunopositive cells were decreased
in brain of mice administered both arsenic and taurine.
Weak expression of 8-nitroguanine immunoreactivity
was observed in neuron cells of mice that were admi-
nistered both arsenic and taurine (Fig. 2, Arsenic
+Taurine). In the cerebella, intensive expression of
8-nitroguanine was found in the Purkinje’s cells and
granule cells. Relatively weak expression of 8-nitrogua-
nine immunopositive cells was observed in granule
cells of the cerebella that were administered both of
arsenic and taurine.
Quantitative analysis of the formation of 8-nitroguanine
in the mice cerebrum
We counted the number of immunopositive neuron
cells in the arsenic administrated group, arsenic/taurine
administrated group and control group that exhibited
immunoreactivity of 8-nitroguanine. Quantitative analy-
sis of anti 8-nitroguanine staining neuron cells showed
that the average immunopositive cells in brain tissue
Figure 1 Histopathological changes in brain tissue of mice from each group. Pathological findings in the neuron of mice exposed to
arsenic are observed. Axonal lose, cell shrinkage, evident vacuolar degeneration in cytoplasm and nucleus, karyorrhexis, and karyolysis are
apparent. Relatively slight pathological changes are observed in cells from mice administered both arsenic and taurine. No abnormal histological
changes in the brain tissues are observed in the control group. Bar = 50 µm.
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Page 3 of 6Figure 2 8-Nitroguanine immunoreactivity in the neuron of cerebrum and cerebellum of mice from each group. Little or no expression
of 8-nitroguanine in brain tissue was observed in control group. Intensive expression of 8-nitroguanine was found in neuron cells in the cerebral
cortex exposed to arsenic. Significantly elevated 8-nitroguanine immunoreactivity is observed in the granular cells of cerebellum of mice exposed
to arsenic; 8-nitroguanine expression was primarily distributed in the nucleus. The density and number of 8-nitroguanine immunopositive cells
were decreased in the cerebellum of mice administered both arsenic and taurine. Little or no 8-nitroguanine expression was observed in the
cerebellum of control group. Bar: Cerebrum = 100 µm. Cerebellum = 200 µm.
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than those in the other groups (p <0.01) as shown in
Fig. 3.
Discussion
Although many researches have demonstrated that
arsenic is a neurotoxin substance [13-16], the mechan-
ism of arsenic-induced neurotoxicity is not so clear.
Chaudhuri et al. reported that in neonatal rat brain cells
and human fetal brain cells, NO production was
increased after arsenic treatment [17]. Ding et al.
reported that arsenic induces nitric oxide generation
through activation of inducible nitric oxide synthase
(iNOS). Excessive production of nitric oxide has been
implicated in neurodegenerative diseases [18]. It indi-
cated that arsenic can induce overproduction of NO by
inducing nitric oxide in the brain. A high concentration
of NO reacts with oxyradical to product RNS including
ONOO-, resulting in derangement of cell metabolism,
breakage of DNA/RNA chains and tissue damage [19].
8-Nitroguanine is a product of nucleic acid, which has
been previously damaged by reactive nitrogen species
resulting in further mutations and carcinogenesis
[7,8,20]. In the present study, strong expression of 8-
nitroguanine was shown in cerebral cortex and cerebella
cortex of mice exposed to arsenic sub-chronically.
Our results showed that in the nucleus, where DNA
resides, very intense 8-nitroguanine was present;
whereas in the cytoplasm, the occupational location of
RNA, a weak 8-nitroguanine signal was detected.
Because 8-nitroguanine has a strong expression in neu-
ron cells exposed to arsenic, it may be associated with
DNA damage of nerve cells by arsenic. These results
suggested that arsenic exposure may lead to nucleic acid
damage in neuron cells. Moreover, 8-nitroguanine stain-
ing results demonstrated that 8-nitroguanine was pre-
sented much stronger in the nucleus than in the
cytoplasm. 8-Nitroguanine exhibits rapid depurination
in cells, and it is more stable in RNA than in DNA [21]
indicating that strong expression of strong expression of
8-nitroguanine in arsenic exposure may be associated
with both DNA/RNA damage in the neural cells. Our
previous studies had reported that exposure to arsenic
induced oxidative DNA damage of neurons in cerebral
cortex [22]. These results implied that neurons of cere-
bral and cerebellum cortex may be the major target
cells of arsenic neurotoxicity.
Taurine is the most abundant free amino acid in many
tissues and has protection against adverse effect of ROS
caused by various toxic substances [23-26]. The results
showed relatively light pathological changes and weak
expression of 8-nitroguanine in nervous cells of the
mice administered both arsenic and taurine. It was indi-
cated that administration of taurine can alleviate patho-
logical changes and DNA damage caused by arsenic
through the RNS signal pathway. The protections of
taurine may be associated with the reduction of oxyradi-
cals so as to prevent the reaction of NO with oxyradi-
cals to overproduce ONOO
-. Taurine has been shown
to inhibit iNOS expression in phagocytes, resulting in
suppressed nitric oxide production [27]. For example,
arsenic-induced neuron damage is related to inflamma-
tion, NO, and apoptosis, and many factors (such as
iNOS, ONOO
-, etc) are related to the cause of DNA
damage. In this way, we speculate that the correction of
these molecules and morphological changes may lead to
neurobehavioral improvement in patients, thus, the
treatment using taurine may represent an ideal approach
for improving function after chronic exposure to
arsenate in drinking water. In order to clarify the func-
tional role of the 8-nitroguanine, quantifiable method
for various NO-mediated carcinogenesis models is
under way in our laboratory.
Conclusion
The most important findings of this study suggest that
the neuroprotective effect of taurine against pathological
changes and nucleic acid damage is due to reactive
nitrogen species in cerebrum and cerebellum of mice
exposed to arsenic. The effects are probably mediated
by the inhibition of inflammatory responses (i.e., iNOS).
Taurine itself possessed either free radical scavenging or
Figure 3 Effect of taurine on the formation of 8-nitroguanine
in the cerebral cortex of mice brain exposed to arsenic. 8-
Nitroguanine immunopositive cells in the cortex of mice brain in
the control, arsenic and arsenic/taurine. Each microscopic scoring
damage value represents the mean ± S.E.M of 10 microscopic fields
in each animal. *P < 0.01 compared with the control group, and
##P
< 0.01 compared with the arsenic+taurine group.
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anion formation probably through inhibiting neutrophil
activation. We speculate that the correction of these
molecules and morphological changes may lead to neu-
robehavioral improvement in patients, thus, the treat-
ment using taurine may represent an ideal approach for
improving function after chronic exposure to arsenate in
drinking water.
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